Activation of cell-survival transcription factor NFκB in L1Ig6-stimulated endothelial cells

Journal of Biomedical Materials Research - Part A

Volumn 77, Issue 3, 2006, Pages 542-550

  Reidy, Martin ^a   Zihlmann, Pius ^a   Hubbell, Jeffrey A ^a,b   Hall, Heike ^a  

^a ETH ZURICH   (Switzerland)

^b EPFL   (Switzerland)

Author keywords

Apoptosis; Cell survival; Endothelial cells; HUVECs; NF B

Indexed keywords

CELL SURVIVAL; LIGATION; NUCLEAR FACTORS;

CELL ADHESION; CELL DEATH; ENDOTHELIAL CELLS; IMPLANTS (SURGICAL); LIGANDS;

TRANSCRIPTION FACTORS;

ARGINYLGLYCYLASPARTIC ACID; CELL ADHESION MOLECULE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN L1IG6; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL SURVIVAL; CONTROLLED STUDY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; SKIN FIBROBLAST;

CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; NEURAL CELL ADHESION MOLECULE L1; PROTEIN STRUCTURE, TERTIARY; TRANSCRIPTION FACTOR RELA;

EID: 33748930223     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.30590     Document Type: Article

References (36)

1. Risau W. Mechanisms of angiogenesis. Nature 1997;386:671-674.
2. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000;407:242-248.
3. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003;9:653-660.
4. Hood JD, Frausto R, Kiosses WB, Schwartz MA, Cheresh DA. Differential av integrin-mediated Ras-ERK signalling during two pathways of angiogenesis. J Cell Biol 2003;162:933-943.
5. Duval H, Harris M, Li J, Johnson N, Print C. New insights into the function and regulation of endothelial cell apoptosis. Angiogenesis 2003;6:171-183.
6. Cheresh DA, Stupack DG. Integrin-mediated death: An explanation of the integrin-knockout phenotype? Nat Med 2002;8:193-194.
7. Stupack DG, Cheresh DA. Apoptotic cues from the extracellular matrix: Regulators of angiogenesis. Oncogene 2003;22:9022-9029.
8. Iivanainen E, Kahari VM, Heino J, Elenius K. Endothelial cell-matrix interactions. Microsc Res Tech 2003;60:13-22.
9. Orr AW, Sanders JM, Bevard M, Coleman E, Sarembock IJ, Schwartz MA. The subendothelial extracellular matrix modulates NFκB activation by flow: A potential role in artheriosclerosis. J Cell Biol 2005;169:191-202.
10. Stupack DG, Cheresh DA. Get a ligand, get a life: Integrins, signaling and cell survival. J Cell Sci 2002;115:3729-3738.
11. Legler DF, Doucey MA, Cerottini JC, Bron C, Luescher IF. Selective inhibition of CTL activation by a dipalmitoyl-phospholipid that prevents the recruitment of signaling molecules to lipid rafts. Faseb J 2001;15:1601-1603.
12. Kim YS, Schwabe RF, Qian T, Lemasters JJ, Brenner DA. TRAI L-mediated apoptosis requires NF-kappaB inhibition and the mitochondrial permeability transition in human hepatoma cells. Hepatology 2002;36:1498-1508.
13. Scatena M, Almeida M, Chaisson ML, Fausto N, Nicosia RF, Giachelli CM. NF-κB mediates αvβ3 integrin-induced endothelial cell survival. J Cell Biol 1998;141:1083-1093.
14. Scatena M, Giachelli C. The α(v)β3 integrin, NF-κB, osteoprotegerin endothelial cell survival pathway. Potential role in angiogenesis. Trends Cardiovas Med 2002;12:83-88.
15. Baldwin AS Jr. The NF-κ B and I κ B proteins: New discoveries and insights. Annu Rev Immunol 1996;14:649-683.
16. De Martin R, Hoeth M, Hofer-Warbinek R, Schmid JA. The transcription factor NF-κ B and the regulation of vascular cell function. Arterioscler Thromb Vasc Biol 2000;20:E83-E88.
17. Duriez PJ, Wong F, Dorovini-Zis K, Shahidi R, Karsan A. A1 functions at the mitochondria to delay endothelial apoptosis in response to tumor necrosis factor. J Biol Chem 2000;275:18099-18107.
18. Bonizzi G, Karin M. The two NF-KB activation pathways and their role in innate and adaptive immunity. Trends Immunol 2004;25:280-288.
19. Buch FH, Hancock WW, Ferran C. Protective genes expressed in endothelial cells: A regulatory response to injury. Immunol Today 1997;18:483-486.
20. Stehlik C, De Martin R, Kumabashiri I, Schmid JA, Binder BR, Lipp J. Nuclear factor (NF)-κB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor α-induced apoptosis. J Exp Med 1998;188: 211-216.
21. Karin M, Lin A. NFκB at the crossroads of life and death. Nature Immunol 2002;3:221-227.
22. Gosh S, Karin M. Missing pieces in the NFκB puzzle. Cell 2002;109:81-96.
23. Hall H, Baechi T, Hubbell JA. Molecular properties of fibrin-based hydrogels for angiogensis in vitro. Microvas Res 2001; 62:315-326.
24. vβ3- integrin induce HUVEC process extension in vitro and angiogenesis in vivo. Angiogenesis 2004;7:213-223.
25. Hall H, Hubbell JA. Matrix-bound sixth Ig-like domain of cell adhesion molecule L1 acts as an angiogenic factor by ligating αvβ3-integrin and activating VEGF-R2. Microvas Res 2004;68: 169-178.
26. Montgomery AMP, Becker JC, Siu CH, Lemmon VP, Cheresh DA, Pancook JD, Zhao X, Reisfeld RA. Human neural cell adhesion molecule L1 and rat homologue NILE are ligands for integrin αvβ3. J Cell Biol 1996;132:475-485.
27. Felding-Habermann B, Silletti S, Mei F, Siu CH, Yip P, Brooks P, Cheresh DA, O'Toole TE, Ginsberg MH, Montgomery AMP. A single immunoglobulin-like domain of the human neural adhesion molecule L1 supports adhesion by multiple vascular and platelet integrins. J Cell Biol 1997;139:1567-1581.
28. Andrews PA, Jones JA. Characterization of binding proteins from ovarian carcinoma and kidney tubule cells that are specific for cisplatin modified DNA. Cancer Commun 1991;3:93-102.
29. Bodmer JL, Holler N, Reynard S, Vinciguerra P, Schneider P, Juo P, Blenis J, Tschopp J. Trail receptor-2 signals apoptosos through FADD and caspase-8. Nature Cell Biol 2000;2:241-243.
30. Ilan N, Mahooti S, Madri JA. Distinct signal transduction pathways are utilized during the tube formation and survival phases of in vitro angiogenesis. J Cell Sci 1998;111:3621-3631.
31. Carmeliet P. Integrin indecision. Nat Med 2002;8:14-16.
32. Hynes R. A reevaluation of integrins as regulators of angiogenesis. Nature Med 2002;8:918-921.
33. Belkin AM, Stepp MA. Integrins as receptors for laminins. Microsc Res Tech 2000;51:280-301.
34. Heino J. The collagen receptor integrins have distinct ligand recognition and signaling functions. Matrix Biol 2000;19:319-323.
35. Schwartz MA, Assoian RK. Integrins and cell proliferation: Regulation of cyclin-dependent kinases via cytoplasmic signaling pathways. J Cell Sci 2001;114:2553-2560.
36. Sechler JL, Corbett SA, Wenk MB, Schwarzbauer JE. Modulation of cell-extracellular matrix interactions. Ann NY Acad Sci 1998;857:143-154.